Format

Send to

Choose Destination
PLoS One. 2012;7(11):e48132. doi: 10.1371/journal.pone.0048132. Epub 2012 Nov 7.

Association of GSTP1 Ile105Val polymorphism and risk of head and neck cancers: a meta-analysis of 28 case-control studies.

Author information

1
Department of Otorhinolaryngology-Head & Neck Surgery, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.

Abstract

BACKGROUND AND AIMS:

The Glutathione S-transferase P1 (GSTP1) polymorphism have been considered a risk modifier for developing head and neck cancer (HNC) in many studies; however, the results of such studies are inconsistent. The aim of this study was to evaluate the possible association between the GSTP1 Ile105Val polymorphism and risk of HNC.

METHOD:

We performed a search in the relevant electronic database and a meta-analysis based on 28 published case-control studies that included 6,404 cases and 6,523 controls. To take into account the possibility of heterogeneity across the studies, a Chi-square based I(2)-statistic test was performed. Crude pooled odds ratios (ORs) with 95% confidence intervals (CIs) were assessed using both fixed-effects and random-effects models.

RESULTS:

The results of this meta-analysis showed that the GSTP1 Ile105Val polymorphism was not significantly associated with risk of HNC in the overall study population (pooled OR 1.00, 95% CI 0.92-1.09) or in subgroup analyses stratified by ethnicity, sample size, tumor site or publication year. Moreover, substantial evidence of heterogeneity among the studies was observed. Publication year was identified as the main cause of heterogeneity.

CONCLUSION:

This meta-analysis does not support a significant association between the GSTP1 Ile105Val polymorphism and risk of HNC.

PMID:
23144854
PMCID:
PMC3492338
DOI:
10.1371/journal.pone.0048132
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center